User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 6 results.
    • Journal article
    Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).
    Franchimont, Denis Ferrante, Marc Louis, Edouard De Vos, Martine Dewit, Olivier[UCL] Van Hootegem, Philippe Moreels, Tom[UCL] Liefferinckx, Claire Bossuyt, Peter Baert, Filip Rahier, Jean-François[UCL] Vermeire, Séverine (2018) Acta gastro-enterologica Belgica — Vol. 81, no. 1, p. 49-53 (2018)
    • Journal article
    Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
    Liefferinckx, Claire Bottieau, Jérémie Toubeau, Jean-François Thomas, Debby Rahier, Jean-François[UCL] Louis, Edouard Baert, Filip Dewint, Pieter Pouillon, Lieven Lambrecht, Guy Vallée, François Vermeire, Severine Bossuyt, Peter Franchimont, Denis (2022) Inflammatory bowel diseases — Vol. 28, no. 2, p. 208-217 (2022)
    • Journal article
    New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis.
    Minsart, Charlotte Liefferinckx, Claire Lemmers, Arnaud Dressen, Cindy Quertinmont, Eric Leclercq, Isabelle[UCL] Devière, Jacques Moreau, Richard Gustot, Thierry (2020) Scientific reports — Vol. 10, no. 1, p. 5557 [1-15] (2020)
    • Journal article
    Long-term clinical effectiveness of ustekinumab in patients with Crohn's disease who failed biological therapies: a national cohort study.
    Liefferinckx, Claire Verstockt, Bram Gils, Ann Noman, Maja Van Kemseke, Catherine Macken, Elisabeth De Vos, Martine Van Moerkercke, Wouter Rahier, Jean-François[UCL] Bossuyt, Peter Dutré, Joris Humblet, Evelien Staessen, Dirk Peeters, Harald Van Hootegem, Philippe Louis, Edouard Franchimont, Denis Baert, Filip Vermeire, Séverine Belgian Inflammatory Bowel Disease Research and Development Group (BIRD group) (2019) Journal of Crohn's & colitis — Vol. 13, no. 11, p. 1401-1409 (2019)
    • Journal article
    Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
    Fierens, Liselotte Liefferinckx, Claire Hoefkens, Eveline Lobatòn, Triana Dreesen, Erwin Sabino, João Ferrante, Marc IBD Research and Development (BIRD) group Rahier, Jean-François[UCL] (2022) Journal of Crohn's & colitis — Vol. 16, no.7, p. 1059-1069 (2022)
    • Speech
    Real world validation of a prognostic clinical index to predict steroid response in acute severe colitis: a single tertiary center retrospective study
    Bouillon, Vincent de Terwangne, Christophe[UCL] Minsart, Charlotte Liefferinckx, Claire Franchimont, Denis Cremer, Anneline (2024) UEG Week — Vienna, Austria